Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3010% above fair value
$101.25−0.35 (-0.34%)
Close on Nov 12, 2026Market cap $6.61BP/E 25.0Yield –
Lantheus operating margin
Operating margin is operating income as a percentage of revenue.
Lantheus's operating margin for the twelve months ending Sep 30, 2026 was 18.6%. For fiscal 2025 it was 20.2%, against 29.8% the year before. The highest annual figure on record is 29.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.2% | −9.6 |
| FY2024 | Dec 31, 2024 | 29.8% | +1.7 |
| FY2023 | Dec 31, 2023 | 28.1% | +24.3 |
| FY2022 | Dec 31, 2022 | 3.9% | +18.2 |
| FY2021 | Dec 31, 2021 | -14.3% | −13.1 |
| FY2020 | Dec 31, 2020 | -1.2% | −16.1 |
| FY2019 | Dec 31, 2019 | 14.9% | −3.9 |
| FY2018 | Dec 31, 2018 | 18.8% | +3.1 |
| FY2017 | Dec 31, 2017 | 15.6% | −3.1 |
| FY2016 | Dec 31, 2016 | 18.7% | +4.3 |
| FY2015 | Dec 31, 2015 | 14.5% | +1.4 |
| FY2014 | Dec 31, 2014 | 13.1% | +19.7 |
| FY2013 | Dec 31, 2013 | -6.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 8.3% | −3.1 |
| Q2 FY2026 | Jun 30, 2026 | 25.8% | +2.5 |
| Q1 FY2026 | Mar 31, 2026 | 21.6% | −5.8 |
| Q4 FY2025 | Dec 31, 2025 | 19.0% | −10.1 |
| Q3 FY2025 | Sep 30, 2025 | 11.4% | −24.0 |
| Q2 FY2025 | Jun 30, 2025 | 23.3% | −2.8 |
| Q1 FY2025 | Mar 31, 2025 | 27.4% | −1.4 |
| Q4 FY2024 | Dec 31, 2024 | 29.1% | −9.7 |
| Q3 FY2024 | Sep 30, 2024 | 35.3% | +0.2 |
| Q2 FY2024 | Jun 30, 2024 | 26.1% | −12.5 |
| Q1 FY2024 | Mar 31, 2024 | 28.8% | +31.9 |
| Q4 FY2023 | Dec 31, 2023 | 38.8% | +104.1 |
| Q3 FY2023 | Sep 30, 2023 | 35.1% | −0.7 |
| Q2 FY2023 | Jun 30, 2023 | 38.6% | +10.3 |
| Q1 FY2023 | Mar 31, 2023 | -3.1% | −31.3 |
| Q4 FY2022 | Dec 31, 2022 | -65.2% | −38.0 |
| Q3 FY2022 | Sep 30, 2022 | 35.8% | +49.9 |
| Q2 FY2022 | Jun 30, 2022 | 28.3% | +54.8 |
| Q1 FY2022 | Mar 31, 2022 | 28.2% | +11.3 |
| Q4 FY2021 | Dec 31, 2021 | -27.3% | −26.7 |
| Q3 FY2021 | Sep 30, 2021 | -14.0% | −8.1 |
| Q2 FY2021 | Jun 30, 2021 | -26.5% | −18.1 |
| Q1 FY2021 | Mar 31, 2021 | 16.9% | +9.0 |
| Q4 FY2020 | Dec 31, 2020 | -0.6% | −14.5 |
| Q3 FY2020 | Sep 30, 2020 | -5.9% | −15.9 |
| Q2 FY2020 | Jun 30, 2020 | -8.4% | −25.4 |
| Q1 FY2020 | Mar 31, 2020 | 7.9% | −10.8 |
| Q4 FY2019 | Dec 31, 2019 | 13.9% | −5.7 |
| Q3 FY2019 | Sep 30, 2019 | 9.9% | −8.6 |
| Q2 FY2019 | Jun 30, 2019 | 17.0% | −1.6 |
| Q1 FY2019 | Mar 31, 2019 | 18.7% | +0.4 |
| Q4 FY2018 | Dec 31, 2018 | 19.6% | +8.3 |
| Q3 FY2018 | Sep 30, 2018 | 18.5% | +2.5 |
| Q2 FY2018 | Jun 30, 2018 | 18.6% | −1.5 |
| Q1 FY2018 | Mar 31, 2018 | 18.3% | +3.7 |
| Q4 FY2017 | Dec 31, 2017 | 11.3% | −5.0 |
| Q3 FY2017 | Sep 30, 2017 | 16.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 20.1% | – |
| Q1 FY2017 | Mar 31, 2017 | 14.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 16.3% | – |
See a number that looks wrong?